Skip to main content

Monitoring Scleroderma After Diagnosis

Systemic sclerosis is a multi-system disease that varies from person to person. Monitoring can help catch changes as they happen, so that disease management can be as proactive as possible. Here’s a breakdown of how care teams may monitor scleroderma progression.

Here’s a breakdown of how care teams may monitor scleroderma progression:

How this presents

Swollen, painful fingers with a triphasic color change — white, then blue or purple, then red — triggered by cold or stress.

Baseline evaluation

Nailfold capillaroscopy (a non-invasive scope exam of the small blood vessels at the base of your fingernails) to confirm secondary RP — the form linked to scleroderma, as opposed to primary Raynaud’s.

Ongoing monitoring

Tracked through your medical history at follow-up visits.

Indicators of progression

Tissue damage from restricted blood flow, or ischemic ulcers (open sores caused by inadequate blood supply to the skin) that don’t heal even after rewarming.

How this presents

Puffy fingers, or tightened, thickened skin over the digits, which can later become contracted and hard to bend

Baseline evaluation

Measurement of skin thickness using a modified Rodnan Skin Score (mRSS), which is a hands-on exam where a clinician scores skin thickness at multiple body sites.

Ongoing monitoring

Repeat mRSS scoring alongside a hand function assessment.

Indicators of progression

Increasing skin thickness or a rising mRSS score.

How this presents

Fatigue, exercise intolerance, shortness of breath.

Baseline evaluation

High-resolution CT (HRCT) and pulmonary function tests (PFTs).

Ongoing monitoring

Repeat PFTs, followed by HRCT if lung function is declining or symptoms appear.

Indicators of progression

More fibrotic changes on HRCT, declining PFT results, or new or worsening respiratory symptoms

How this presents

Fatigue, exercise intolerance, shortness of breath, dizziness, swelling (edema), chest pain.

Baseline evaluation

Echocardiogram (an ultrasound of the heart) and PFTs.

Ongoing monitoring

Clinical assessment of dyspnea, NT-proBNP blood testing (a blood test that measures a hormone released when the heart is under strain), and repeat echocardiograms.

Indicators of progression

Worsening symptoms, hemodynamic changes (shifts in how blood is flowing through the heart and lungs, often picked up on echocardiogram), or an increased burden of telangiectasia (visible small blood vessels).

How this presents

Headache, blurred vision, shortness of breath, fatigue.

Baseline evaluation

Blood pressure check, plus urine or serum creatinine testing (a blood and urine test that measures how well the kidneys are filtering waste) if symptoms are present.

Ongoing monitoring

Blood pressure checks at home, plus urine or serum creatinine testing if symptoms appear.

Indicators of progression

Acute kidney injury or renal failure, hypertensive retinopathy (damage to blood vessels in the eye from severe high blood pressure), or hypertensive encephalopathy (brain swelling and dysfunction caused by a severe, rapid rise in blood pressure). This is a medical emergency. If you notice a sudden blood pressure spike alongside these symptoms, seek care immediately.

How this presents

Acid reflux (GERD), difficulty swallowing, unexplained weight loss, abdominal symptoms.

Baseline evaluation

If symptoms are present, GI tract imaging (upper endoscopy, a scope placed to look at the lining of the esophagus and stomach).

Ongoing monitoring

Repeat GI tract imaging if symptoms appear or change.

Indicators of progression

Worsening reflux, symptoms or lab tests indicating small intestinal bacterial overgrowth (SIBO) requiring antibiotic treatment, malabsorption (the body’s inability to properly absorb nutrients from food), or intestinal pseudo-obstruction (symptoms of a bowel blockage without an actual physical obstruction).

How this presents

Pain, stiffness, weakness, symptoms of carpal tunnel syndrome.

Baseline evaluation

Physical exam, creatine phosphokinase (CPK) bloodwork (a test that measures an enzyme released when muscle is damaged), and X-rays as needed.

Ongoing monitoring

Repeat physical exam, CPK, and X-rays as needed.

Indicators of progression

Joint contractures or tendon friction rubs.

Scleroderma Terms, Explained Simply

Find clear, simple definitions for common scleroderma medical terms.